U.S. FDA approves Celltrion's OMLYCLO ® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR ®

[
U.S. FDA approves Celltrion's OMLYCLO ® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR ®
[og_img]
https://www.investing.com/news/press-releases/us-fda-approves-celltrions-omlyclo–omalizumabigec-as-the-first-and-only-biosimilar-with-interchangeability-designation-referencing-xolair–93CH-3916608


Investing.com